SERINC2 and leukemia: The upregulated lnc-eRNA SEELA enhances the chromatin occupancy of histone modifiers by directly interacting with K31 aa of histone H4, thereby promoting enhancer activity and SERINC2 expression to affect sphingolipid metabolism during leukemia progression.